Skip to main content
. 2023 Nov 24;8(1):e001235. doi: 10.1136/tsaco-2023-001235

Table 5.

Comparison of patients stratified by operative vs. non-operative treatment

Operative (N=110, 56.4%) Non-operative (N=85, 43.6%) P value
Demographics
 Age, years 69.1±7.6 73.4±9.2 <0.001
 Male 84 (76.4%) 53 (62.4%) 0.04
Medical comorbidities
 Diabetes mellitus 26 (23.6%) 22 (25.9%) 0.74
 Coronary artery disease 19 (17.3%) 11 (12.9%) 0.43
 COPD 6 (5.5%) 3 (3.5%) 0.73
 CVA/TIA 6 (5.5%) 4 (4.7%) 1.00
 Congestive heart failure 2 (1.8%) 2 (2.4%) 1.00
 CKD/ESRD 4 (3.6%) 7 (8.2%) 0.22
 ≥2 comorbidities 17 (15.5%) 8 (9.4%) 0.28
Mechanism of injury
 Fall—ground level 21 (19.1%) 39 (45.9%) <0.001
 Fall—height 26 (23.6%) 18 (21.2%) 0.73
 Motor vehicle collision 58 (52.7%) 23 (27%) <0.001
 Pedestrian struck 4 (3.6%) 4 (4.7%) 0.73
 Crush/industrial 1 (0.9%) 1 (1.2%) 0.85
Any associated injury 80 (72.7%) 65 (76.5%) 0.62
Any additional orthopedic injury 63 (57.3%) 51 (60%) 0.77
Letournel classification
 Posterior wall 22 (20%) 10 (11.8%) 0.17
 Posterior column 0 (0%) 1 (1.2%) 0.90
 Posterior wall+posterior column 19 (17.3%) 2 (2.4%) <0.001
 Transverse 3 (2.7%) 17 (20%) <0.001
 Transverse+posterior wall 11 (10%) 1 (1.2%) 0.025
 T-type 8 (7.3%) 5 (5.9%) 0.92
 Anterior wall 1 (0.9%) 2 (2.4%) 0.82
 Anterior column 7 (6.4%) 6 (7.1%) 0.85
 Anterior column posterior hemitransverse 20 (18.2%) 13 (15.3%) 0.70
 Associated both column 19 (17.3%) 28 (32.9%) 0.018
Hip dislocation 53 (48.2%) 8 (9.4%) <0.001
Femoral head injury 13 (11.8%) 1 (1.2%) 0.01
Marginal impaction 36 (32.7%) 4 (4.7%) <0.001
Any complication 39 (35.5%) 34 (40%) 0.55

Bold entries denote statistical significance.

CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; ESRD, end-stage renal disease; TIA, transient ischemic attack.